Capricor Therapeutics Inc Stock, NASDAQ:CAPR
8840 Wilshire Boulevard, 2nd floor, Beverly Hills, California 90211
United States of America
Number of Employees: 26
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in Beverly Hills, CA.